selected publications
- Decoding Serum Metabolic Secrets of Nontuberculous Mycobacterial Pulmonary Disease. The Journal of infectious diseases. 2024 Academic Article GET IT
- The Bacillus subtilis yqgC - sodA operon protects magnesium-dependent enzymes by supporting manganese efflux. 2024 GET IT
- Metabolic Rewiring of Mycobacterium tuberculosis upon Drug Treatment and Antibiotics Resistance. Metabolites. 2024 Review GET IT
- Mycobacterium smegmatis, a Promising Vaccine Vector for Preventing TB and Other Diseases: Vaccinomics Insights and Applications. Vaccines. 2023 Review GET IT
- Insights into the central role of N-acetyl-glucosamine-1-phosphate uridyltransferase (GlmU) in peptidoglycan metabolism and its potential as a therapeutic target. The Biochemical journal. 2023 Review GET IT
- Editorial: Bacterial metabolomics approach towards antimicrobials and resistance. Frontiers in microbiology. 2023 Editorial Article GET IT
- Mutations in rpoB That Confer Rifampicin Resistance Can Alter Levels of Peptidoglycan Precursors and Affect β-Lactam Susceptibility. mBio. 2023 Academic Article GET IT
- Bacterial Metabolomics Approach towards Antimicrobials and Resistance. 2023 Book
- Genomic surveillance of bacterial pathogens. Academic Press. 2023 Chapter
- Mycobacterium smegmatis, a Promising Vaccine Vector for Preventing TB and Other Diseases: Vaccinomics Insights and Applications. 2023 Article
- Nanosensors for Futuristic Smart and Intelligent Healthcare Systems. 2023 Book
-
Therapeutic Potentials of Immunometabolomic Modulations Induced by Tuberculosis Vaccination.
Vaccines.
2022
Review
GET IT
Times cited: 4 - Immunotherapy: an alternative promising therapeutic approach against cancers. Molecular biology reports. 2022 Review GET IT
- B-Cell-Based Immunotherapy: A Promising New Alternative. Vaccines. 2022 Review GET IT
- Chemical-genetic interaction mapping links carbon metabolism and cell wall structure to tuberculosis drug efficacy. Proceedings of the National Academy of Sciences of the United States of America. 2022 Academic Article GET IT
-
A hydrogel-based implantable multidrug antitubercular formulation outperforms oral delivery.
Nanoscale.
2021
Academic Article
GET IT
Times cited: 4 -
Unique C-terminal extension and interactome of Mycobacterium tuberculosis GlmU impacts it's in vivo function and the survival of pathogen.
The Biochemical journal.
2021
Academic Article
GET IT
Times cited: 2 -
Transcriptional regulator-induced phenotype screen reveals drug potentiators in Mycobacterium tuberculosis.
Nature microbiology.
2020
Academic Article
GET IT
Times cited: 10 -
Mode-of-action profiling reveals glutamine synthetase as a collateral metabolic vulnerability of M. tuberculosis to bedaquiline.
Proceedings of the National Academy of Sciences of the United States of America.
2019
Academic Article
GET IT
Times cited: 30 -
The bifunctional protein GlmU is a key factor in biofilm formation induced by alkylating stress in Mycobacterium smegmatis.
Research in microbiology.
2019
Academic Article
GET IT
Times cited: 7 -
Computational Sampling and Simulation Based Assessment of Novel Mycobacterium tuberculosis Glutamine Synthetase Inhibitors: Study Involving Structure Based Drug Design and Free Energy Perturbation.
Current topics in medicinal chemistry.
2016
Academic Article
GET IT
Times cited: 7 -
Depletion of M. tuberculosis GlmU from Infected Murine Lungs Effects the Clearance of the Pathogen.
PLoS pathogens.
2015
Academic Article
GET IT
Times cited: 32 -
Discovery of novel lysine ɛ-aminotransferase inhibitors: An intriguing potential target for latent tuberculosis.
Tuberculosis (Edinburgh, Scotland).
2015
Academic Article
GET IT
Times cited: 13 -
Structure-based design of diverse inhibitors of Mycobacterium tuberculosis N-acetylglucosamine-1-phosphate uridyltransferase: combined molecular docking, dynamic simulation, and biological activity.
Journal of molecular modeling.
2015
Academic Article
GET IT
Times cited: 13 -
Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
Journal of molecular graphics & modelling.
2015
Academic Article
GET IT
Times cited: 13 -
Targeting NAMPT for Therapeutic Intervention in Cancer and Inflammation: Structure-Based Drug Design and Biological Screening.
Chemical biology & drug design.
2015
Academic Article
GET IT
Times cited: 12 -
Identification of potential Mycobacterium tuberculosis topoisomerase I inhibitors: a study against active, dormant and resistant tuberculosis.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
2015
Academic Article
GET IT
Times cited: 15 -
Structure-guided design and development of novel benzimidazole class of compounds targeting DNA gyraseB enzyme of Staphylococcus aureus.
Bioorganic & medicinal chemistry.
2014
Academic Article
GET IT
Times cited: 16 -
Development of novel N-linked aminopiperidine-based mycobacterial DNA gyrase B inhibitors: scaffold hopping from known antibacterial leads.
International journal of antimicrobial agents.
2013
Academic Article
GET IT
Times cited: 30 -
Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
European journal of medicinal chemistry.
2013
Academic Article
GET IT
Times cited: 56 -
Identification of novel inhibitors against Mycobacterium tuberculosis L-alanine dehydrogenase (MTB-AlaDH) through structure-based virtual screening.
Journal of molecular graphics & modelling.
2013
Academic Article
GET IT
Times cited: 37 -
Substrate-bound crystal structures reveal features unique to Mycobacterium tuberculosis N-acetyl-glucosamine 1-phosphate uridyltransferase and a catalytic mechanism for acetyl transfer.
The Journal of biological chemistry.
2012
Academic Article
GET IT
Times cited: 22